Anhui Heryi Pharmaceutical Co.,ltd.
峆一药业
Anhui Heryi Pharmaceutical Co.,ltd.
Biotech/Healthcare
Heyi Pharmaceutical focuses on the R&D, production, and sales of pharmaceutical intermediates. Its main products include intermediates for pranlukast, crude zaltoprofen and its intermediates, resveratrol intermediates, sarpogrelate hydrochloride intermediates, atazanavir intermediates, nilotinib…
Latest round: IPO (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-02-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.